Verastem Oncology Provides Update on RAMP 201 Study Evaluating VS-6766 ± Defactinib in Low-Grade Serous Ovarian Cancer
Interim Analysis Findings Support Continued Evaluation of Both Monotherapy and Combination Therapy Encouraging Efficacy Results Include Independently Confirmed Responses in...